Marshall Wace North America’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,269
Closed -$235K 1443
2020
Q3
$235K Buy
+7,269
New +$235K ﹤0.01% 1109